These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 36059524

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hemorrhage complications in obstetric antiphospholipid syndrome: Risk factors and association with adverse pregnancy outcomes.
    Luo Y, Jin J, Yan Y, Zhang M, Hou L, Hou Y, Pei Q, Li C.
    Front Immunol; 2023; 14():1145146. PubMed ID: 37006292
    [Abstract] [Full Text] [Related]

  • 3. Clinical features associated with pregnancy outcomes in women with positive antiphospholipid antibodies and previous adverse pregnancy outcomes: a real-world prospective study.
    Li X, Deng X, Duan H, Zeng L, Zhou J, Liu C, Guo X, Liu X.
    Clin Rheumatol; 2021 Jan; 40(1):193-204. PubMed ID: 32514680
    [Abstract] [Full Text] [Related]

  • 4. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G, Berghella V, Maruotti GM, Ghi T, Rizzo G, Simonazzi G, Rizzo N, Facchinetti F, Dall'Asta A, Visentin S, Sarno L, Xodo S, Bernabini D, Monari F, Roman A, Eke AC, Hoxha A, Ruffatti A, Schuit E, Martinelli P, PREGNANTS (PREGNancy in women with ANTiphospholipid Syndrome) working group.
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [Abstract] [Full Text] [Related]

  • 5. Factors associated with adverse pregnancy outcomes in women with antiphospholipid syndrome: A multicenter study.
    Deguchi M, Yamada H, Sugiura-Ogasawara M, Morikawa M, Fujita D, Miki A, Makino S, Murashima A.
    J Reprod Immunol; 2017 Aug; 122():21-27. PubMed ID: 28837832
    [Abstract] [Full Text] [Related]

  • 6. [Etiology and clinical characteristics of pregnancy-emerged thrombocytopenia].
    Chen Z, Liang MY, Wang JL.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):834-9. PubMed ID: 22333233
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.
    Fredi M, Andreoli L, Aggogeri E, Bettiga E, Lazzaroni MG, Le Guern V, Lojacono A, Morel N, Piette JC, Zatti S, Costedoat-Chalumeau N, Tincani A.
    Front Immunol; 2018 Nov; 9():864. PubMed ID: 29867924
    [Abstract] [Full Text] [Related]

  • 11. [Obstetric Antiphospholipid Syndrome: Insights on the Diagnosis, Treatment, and Hot Issues].
    Gao R, Qin L.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May 20; 55(3):513-520. PubMed ID: 38948301
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical characteristics and pregnancy outcomes of non-criteria obstetric antiphospholipid syndrome].
    Yang XX, Sun YD, Zhao JL, Tian XP, Zeng XF, Li MT.
    Zhonghua Nei Ke Za Zhi; 2021 Sep 01; 60(9):812-816. PubMed ID: 34445817
    [Abstract] [Full Text] [Related]

  • 15. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
    Lefkou E, Varoudi K, Pombo J, Jurisic A, Jurisic Z, Contento G, Girardi G.
    Biochem Pharmacol; 2020 Dec 01; 182():114217. PubMed ID: 32926874
    [Abstract] [Full Text] [Related]

  • 16. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases.
    Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Sáez-Comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Tincani A, Marozio L, Espinosa G, Cervera R, Ríos-Garcés R, De Carolis S, Latino O, LLurba E, Chighizola CB, Gerosa M, Pengo V, Lundelin K, Rovere-Querini P, Canti V, Mayer-Pickel K, Reshetnyak T, Hoxha A, Tabacco S, Stojanovich L, Gogou V, Varoudis A, Arnau A, Ruiz-Hidalgo D, Trapé J, Sos L, Stoppani C, Martí-Cañamares A, Farran-Codina I, EUROAPS Study Group.
    Autoimmun Rev; 2019 Apr 01; 18(4):406-414. PubMed ID: 30772493
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome.
    Yelnik CM, Lambert M, Drumez E, Le Guern V, Bacri JL, Guerra MM, Laskin CA, Branch DW, Sammaritano LR, Morel N, Guettrot-Imbert G, Launay D, Hachulla E, Hatron PY, Salmon JE, Costedoat-Chalumeau N.
    Lupus; 2018 Sep 01; 27(10):1679-1686. PubMed ID: 30016929
    [Abstract] [Full Text] [Related]

  • 19. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
    van Hoorn ME, Hague WM, van Pampus MG, Bezemer D, de Vries JI, FRUIT Investigators.
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb 01; 197():168-73. PubMed ID: 26771908
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.